RxDoctor Payments Data

Abigail Cannata

Physician Assistant · Fayetteville, NCNPI 1700586195

Payments from drug & device makers

$3,087in general payments, 2019–2025

Across 140 payments — averaging $22.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$1K
  • Gilead$789
  • Merck$489
  • Paratek Pharmaceuticals, Inc.$244
  • Insmed, Inc.$207
  • AbbVie$156
  • plus $185 from 5 others

What the payments were for

  • Food & beverage$3,05999%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,087 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$67,421
Medicare patients
268
Services billed
555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala195$817,246
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf47$227,978
RukobiaFostemsavir Tromethamine11$113,426
GenvoyaElviteg/Cob/Emtri/Tenof Alafen23$90,487
DescovyEmtricitabine/Tenofov Alafenam27$62,262
OdefseyEmtricitab/Rilpiviri/Tenof Ala13$53,140
DelstrigoDoravirine/Lamivu/Tenofov Diso20$51,357
DovatoDolutegravir Sodium/Lamivudine13$44,830
JulucaDolutegravir/Rilpivirine12$44,494
TivicayDolutegravir Sodium18$43,838
PrezcobixDarunavir/Cobicistat13$32,829
Cefepime Hcl13$3,164
Daptomycin14$2,466
Dapsone20$830
Rifampin19$801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Genvoya, Descovy$789$969,994245 claims
Viiv Healthcare CompanyRukobia, Dovato, Juluca, Tivicay$1,017$246,58854 claims
MerckDelstrigo$489$51,35720 claims
Johnson & JohnsonPrezcobix$44$32,82913 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Fayetteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →